Fig. 1From: Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypesFlow chart of cases used for analysis. The whole process of identification of the patients that meet study criteria is shown in this chart. 294 patients were used for final analysisBack to article page